Drug maker Bristol-Myers Squibb foresees significant effects on its business from the Patient Protection and Affordable Care Act, company executives told attendees of the its recent shareholder meeting.
http://www.drugstorenews.com/article/healthcare-reform-law-provisions-could-affect-pharmaceutical-innovation-bristol-myers-squibb
http://www.drugstorenews.com/article/healthcare-reform-law-provisions-could-affect-pharmaceutical-innovation-bristol-myers-squibb
No comments:
Post a Comment